Compare EARN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EARN | OSUR |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.2M | 207.2M |
| IPO Year | 2012 | 2000 |
| Metric | EARN | OSUR |
|---|---|---|
| Price | $4.72 | $4.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $5.38 | $3.00 |
| AVG Volume (30 Days) | 416.2K | ★ 794.8K |
| Earning Date | 06-16-2026 | 05-06-2026 |
| Dividend Yield | ★ 20.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $7.69 | $4.48 |
| Revenue Next Year | $19.57 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.27 | $2.08 |
| 52 Week High | $6.08 | $4.33 |
| Indicator | EARN | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 69.86 |
| Support Level | $4.50 | $2.93 |
| Resistance Level | $4.77 | N/A |
| Average True Range (ATR) | 0.10 | 0.22 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 42.05 | 78.72 |
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.